By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Consort Medical, a UK-based manufacturer of drug delivery and medical device technologies, has acquired a roughly 20 percent stake in Atlas Genetics for £1.1 million ($1.8 million).

The firms also announced an alliance, under which Consort's Bespak division will design disposable test cards that will be part of Atlas' rapid, point-of-care molecular diagnostics system. Consort said that it also has received long-term manufacturing rights for the cards.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.